Target Group (Target Group) Risk Assessment

View and export this data going back to 2015. Start your Free Trial

What is Target Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Target Group is: No Data: Cannot be evaluated.

Competitive Comparison of Target Group's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Target Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Target Group's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Target Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Target Group's Risk Assessment falls into.

Target Group (OTCPK:CBDY) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Target Group Risk Assessment Related Terms

Thank you for viewing the detailed overview of Target Group's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Target Group (Target Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Target Group Inc (OTCPK:CBDY) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Hempstead Drive, Hamilton, ON, CAN, L8W 2E7

Website

https://www.targetgroupinc.ca

Target Group Inc is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada. The company generates revenue from the sale of Wisp vaporizer and pod units.

Executives

Barry Alan Katzman	director	36 ADDISON DRIVE, ST. CATHERINES A6 L2S 4B7
Anthony Carlo Zarcone	director	564 NORTH SHORE BLVD., BURLINGTON A6 L7T 1X2
Frank Michael Monte	director	18 BRAESIDE SQ, MARKHAM A6 L3R 0A5
Saul Niddam	director	42 HEATHVIEW AVE, NORTH YORK A6 M2K 2C1
Azmatali Mehrali	officer: CFO	134 BRIDGEPOINTE COURT, AURORA A6 L4H 3H8
Alexander Starr	director, 10 percent owner, officer: President	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Rubin Schindermann	director, 10 percent owner, officer: CEO	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Weinstein Family (2015) Trust	10 percent owner	52 RIDOUT STREET EAST, TILLSONBURG A6 N4G 2E3
Chess Supersite Inc. (canada)	10 percent owner	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Nava Starr	other: See Remarks	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
James M Cassidy	director, 10 percent owner, officer: president	215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop	director, 10 percent owner, officer: vice president	9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212